This effort, which will enhance deCODE's proprietary gene and drug target discovery work and may provide genetic
markers for
additional diagnostic development, will leverage Illumina's Sentrix ® HumanHap BeadChips; Infinium ™ assay and LIMS (laboratory information management system); as well as analysis and visualization tools from Illumina's BeadStudio software.